CEO Heo Seung-beom buys 10,000 shares at 7,922 won via open market purchase
Samil Pharmaceutical's CEO and Chairman Heo Seung-beom purchased 10,000 common shares at 7,922 won per share on May 22, 2026, increasing his stake from 9.15% to 9.20%.
KOSPI Filing Information
Report on Ownership of Specific Securities by Executives and Major Shareholders